Jorn Aldag - Net Worth and Insider Trading
Jorn Aldag Net Worth
The estimated net worth of Jorn Aldag is at least $64,044 dollars as of 2024-05-02. Jorn Aldag is the CEO of HOOKIPA Pharma Inc and owns about 71,952 shares of HOOKIPA Pharma Inc (HOOK) stock worth over $64,044. Details can be seen in Jorn Aldag's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jorn Aldag has not made any transactions after 2023-07-11 and currently still holds the listed stock(s).
Transaction Summary of Jorn Aldag
Jorn Aldag Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jorn Aldag owns 2 companies in total, including HOOKIPA Pharma Inc (HOOK) , and Cogent Biosciences Inc (COGT) .
Click here to see the complete history of Jorn Aldag’s form 4 insider trades.
Insider Ownership Summary of Jorn Aldag
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HOOK | HOOKIPA Pharma Inc | 2023-07-11 | director & Chief Executive Officer |
| COGT | Cogent Biosciences Inc | 2018-03-28 | director |
Jorn Aldag Latest Holdings Summary
Jorn Aldag currently owns a total of 1 stock. Jorn Aldag owns 71,952 shares of HOOKIPA Pharma Inc (HOOK) as of July 11, 2023, with a value of $64,044.
Latest Holdings of Jorn Aldag
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HOOK | HOOKIPA Pharma Inc | 2023-07-11 | 71,952 | 0.89 | 64,044 |
Holding Weightings of Jorn Aldag
Jorn Aldag Form 4 Trading Tracker
According to the SEC Form 4 filings, Jorn Aldag has made a total of 3 transactions in HOOKIPA Pharma Inc (HOOK) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in HOOKIPA Pharma Inc is the acquisition of 10,000 shares on July 11, 2023, which cost Jorn Aldag around $8,200.
Insider Trading History of Jorn Aldag
- 1
Jorn Aldag Trading Performance
GuruFocus tracks the stock performance after each of Jorn Aldag's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jorn Aldag is -32.15%. GuruFocus also compares Jorn Aldag's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jorn Aldag within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jorn Aldag's insider trading performs compared to the benchmark.
Performance of Jorn Aldag
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.47 |  | | | | |
| Relative Return to S&P 500(%) | -12.23 | | | | | |
Jorn Aldag Ownership Network
Jorn Aldag Owned Company Details
What does HOOKIPA Pharma Inc do?
Who are the key executives at HOOKIPA Pharma Inc?
Jorn Aldag is the director & Chief Executive Officer of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , Chief Medical Officer Katia Schlienger , and 10 percent owner Gilead Sciences Inc .
HOOKIPA Pharma Inc (HOOK) Insider Trades Summary
Over the past 18 months, Jorn Aldag made 3 insider transaction in HOOKIPA Pharma Inc (HOOK) with a net purchase of 20,000. Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera ,
In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.
HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
HOOKIPA Pharma Inc Insider Transactions
Jorn Aldag Mailing Address
Above is the net worth, insider trading, and ownership report for Jorn Aldag. You might contact Jorn Aldag via mailing address: C/o Unum Therapeutics Inc., 200 Cambridge Park Drive Suite 3100, Cambridge Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
